CHIEF MEDICAL OFFICER
Wed, May 1, 2024
May 1
exercised or converted securities in ACLX
18,168 shares @ $6.28
Increased holdings by +203.30%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ACLXArcellx, Inc.
Health CareBiotechnology